Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 11/20 | 0.58 |
| ▸ | DHODH | Q02127 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | C1R | P00736 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7333539 | 0.85 | ELANE (0.74) | ELANEC1RLMNASMN1; SMN2PRSS1 | |
| SCHEMBL7363986 | 0.82 | ELANE (0.66) | ELANEC1RPRSS1 | |
| SCHEMBL7329441 | 0.80 | ELANE (0.63) | ELANEC1RPRSS1 | |
| SCHEMBL7339172 | 0.80 | ELANE (0.63) | ELANEC1RALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL7335445 | 0.79 | C1R (0.62) | ELANEC1RALDH1A1PRSS1 | |
| SCHEMBL8898601 | 0.78 | ELANE (0.64) | ELANEC1RALDH1A1PRSS1MAOB | |
| SCHEMBL8898664 | 0.77 | ELANE (0.63) | ELANEC1RALDH1A1PRSS1MAOB | |
| SCHEMBL8899961 | 0.77 | ELANE (0.63) | ELANEC1RALDH1A1PRSS1MAOB | |
| SCHEMBL8899228 | 0.77 | ELANE (0.63) | ELANEC1RALDH1A1PRSS1MAOB | |
| SCHEMBL10362975 | 0.77 | ELANE (0.63) | ELANEC1RALDH1A1PRSS1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5652237-A | 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes | WARNER-LAMBERT COMPANY (US) | 1997-07-29 | — | — | US | disclosed |
| WO-1996007648-A1 | 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES | WARNER-LAMBERT COMPANY (US) | 1996-03-14 | — | — | WO | disclosed |